Such forward-looking statements involve known and unknown risks, uncertainties, and other factors, including without limitation, those relating to our ability to timely and successfully complete our U.S. Food and Drug Administration (???FDA???) patient Pre-Market Approval (???PMA???) clinical trials, as well as our other clinical trials being conducted around the world, including China; our abilit